ATE452891T1 - Pyrimidopyrimidone als kinaseinhibitoren - Google Patents

Pyrimidopyrimidone als kinaseinhibitoren

Info

Publication number: ATE452891T1
Authority: AT; Austria
Prior art keywords: pyrimidopyrimidones; kinase inhibitors; kinase; inhibitors
Prior art date: 2002-07-25

Application number

AT03771234T

Other languages

English (en)

Inventor

Cleo J Chivikas Connolly

Christopher James Deur

James M Hamby

Denton W Hoyer

Chris Limberakis

Jessica Elisabeth Reed

Mel Conrad Schroeder

Clarke Bentley Taylor

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-25

Filing date

2003-07-21

Publication date

2010-01-15

2003-07-21 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

2010-01-15 Application granted granted Critical

2010-01-15 Publication of ATE452891T1 publication Critical patent/ATE452891T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Urology & Nephrology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Heart & Thoracic Surgery (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Cardiology (AREA)
Ophthalmology & Optometry (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Transplantation (AREA)
Vascular Medicine (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT03771234T 2002-07-25 2003-07-21 Pyrimidopyrimidone als kinaseinhibitoren ATE452891T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US39863802P	2002-07-25	2002-07-25
PCT/IB2003/003359 WO2004011465A1 (en)	2002-07-25	2003-07-21	Kinase inhibitors

Publications (1)

Publication Number	Publication Date
ATE452891T1 true ATE452891T1 (de)	2010-01-15

Family

ID=31188438

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03771234T ATE452891T1 (de)	2002-07-25	2003-07-21	Pyrimidopyrimidone als kinaseinhibitoren

Country Status (18)

Country	Link
US (1)	US7196090B2 (de)
EP (1)	EP1549651B1 (de)
JP (1)	JP2005538992A (de)
AR (1)	AR040513A1 (de)
AT (1)	ATE452891T1 (de)
AU (1)	AU2003249442A1 (de)
BR (1)	BR0312867A (de)
CA (1)	CA2493633C (de)
DE (1)	DE60330694D1 (de)
ES (1)	ES2335659T3 (de)
GT (1)	GT200300150A (de)
HN (1)	HN2003000227A (de)
MX (1)	MXPA05000814A (de)
PA (1)	PA8577501A1 (de)
PE (1)	PE20040688A1 (de)
TW (1)	TW200413375A (de)
UY (1)	UY27906A1 (de)
WO (1)	WO2004011465A1 (de)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8236048B2 (en) *	2000-05-12	2012-08-07	Cordis Corporation	Drug/drug delivery systems for the prevention and treatment of vascular disease
JP4214729B2 (ja) *	2002-07-25	2009-01-28	コニカミノルタホールディングス株式会社	硬化性白インク組成物
US7084270B2 (en)	2002-08-14	2006-08-01	Hoffman-La Roche Inc.	Pyrimido compounds having antiproliferative activity
US7112676B2 (en) *	2002-11-04	2006-09-26	Hoffmann-La Roche Inc.	Pyrimido compounds having antiproliferative activity
RU2350617C2 (ru) *	2003-04-10	2009-03-27	Ф.Хоффманн-Ля Рош Аг	Пиримидиновые соединения, обладающие свойствами селективного ингибирования активности кдр и фрфр
GB0313511D0 (en) *	2003-06-11	2003-07-16	Cyclacel Ltd	Combination
US7371750B2 (en) *	2003-07-29	2008-05-13	Irm Llc	Compounds and compositions as protein kinase inhibitors
TW200526224A (en) *	2003-12-22	2005-08-16	Alcon Inc	Short form c-Maf transcription factor antagonists for treatment of glaucoma
CA2576924A1 (en)	2004-08-31	2006-03-09	F. Hoffmann-La Roche Ag	Amide derivatives of 7-amino-3-phenyl-dihydropyrimido [4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents
US7655651B2 (en)	2004-08-31	2010-02-02	Hoffmann-La Roche Inc.	Amide derivatives of 3-phenyl-dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents
WO2006038112A1 (en) *	2004-10-01	2006-04-13	Warner-Lambert Company Llc	Use of kinase inhibitors to promote neochondrogenesis
FR2876584B1 (fr) *	2004-10-15	2007-04-13	Centre Nat Rech Scient Cnrse	Utilisation de la kenpaullone pour la fabrication de medicaments pour le traitement de la mucoviscidose et de maladies liees a un defaut d'adressage des proteines dans les cellules
JP5271697B2 (ja) *	2005-03-23	2013-08-21	アボットラボラトリーズ	医療装置を介する高親油性薬剤の送達
EP1931667A1 (de) *	2005-09-28	2008-06-18	Ranbaxy Laboratories Limited	Als entzündungshemmende mittel geeignete pyridopyridimidinderivate
EA200801128A1 (ru) *	2005-10-21	2008-10-30	Глэксо Груп Лимитед	Пери-конденсированные трициклические соединения, полезные в качестве антибактериальных средств
CA2633768A1 (en) *	2005-11-10	2007-05-18	Bayer Schering Pharma Aktiengesellschaft	Reduction of restenosis
ATE474842T1 (de) *	2005-11-21	2010-08-15	Anadys Pharmaceuticals Inc	Neues verfahren zur herstellung von 5-amino-3h- thiazoloä4,5-düpyrimidin-2-on
DE602006013878D1 (de)	2005-12-22	2010-06-02	Glaxo Group Ltd	Heterocyclische verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel
KR20080083046A (ko)	2006-01-31	2008-09-12	에프. 호프만-라 로슈 아게	7ｈ-피리도[3,4-ｄ]피리미딘-8-온, 이의 제조 및 단백질키나아제 억제제로서의 용도
US7897762B2 (en) *	2006-09-14	2011-03-01	Deciphera Pharmaceuticals, Llc	Kinase inhibitors useful for the treatment of proliferative diseases
KR20090057416A (ko) *	2006-10-05	2009-06-05	씨브이 쎄러퓨틱스, 인코포레이티드	스테아로일 ＣｏＡ 탈포화효소 억제제로서 사용하기 위한, 바이시클릭 질소 함유 헤테로시클릭 화합물
US7893066B2 (en)	2006-10-05	2011-02-22	Gilead Palo Alto, Inc.	Pyridol[2,3-B]pyrazinones for use as stearoyl CoA desaturase inhibitors
WO2008055842A1 (en) *	2006-11-09	2008-05-15	F. Hoffmann-La Roche Ag	Substituted 6-phenyl-pyrido [2,3-d] pyrimidin-7-one derivatives as kinase inhibitors and methods for using the same
US8131527B1 (en)	2006-12-22	2012-03-06	Astex Therapeutics Ltd.	FGFR pharmacophore compounds
EP2114941B1 (de) *	2006-12-22	2015-03-25	Astex Therapeutics Limited	Bicyclische heterocyclische verbindungen als fgfr-inhibitoren
CA2672213C (en)	2006-12-22	2016-02-16	Astex Therapeutics Limited	Bicyclic amine derivatives as protein tyrosine kinase inhibitors
CA2681560A1 (en) *	2007-04-09	2008-10-16	Cv Therapeutics, Inc.	Pteridinone derivatives for use as stearoyl coa desaturase inhibitors
US20100160339A1 (en) *	2007-05-21	2010-06-24	Mayo Foundation For Medical Education And Research	Treating pancreatitis
KR20100024932A (ko)	2007-06-15	2010-03-08	반유 세이야꾸 가부시끼가이샤	비사이클로아닐린 유도체
WO2009016486A2 (en) *	2007-08-02	2009-02-05	Compugen, Ltd	Use of nmda receptor antagonists for treatment of urologic tumors
GB0720038D0 (en) *	2007-10-12	2007-11-21	Astex Therapeutics Ltd	New compounds
GB0720041D0 (en)	2007-10-12	2007-11-21	Astex Therapeutics Ltd	New Compounds
ES2383331T3 (es) *	2008-02-22	2012-06-20	Irm Llc	Compuestos heterocíclicos y composiciones como inhibidores de las Cinasas C-KIT y PDGFR INHIBITORS
EP2276748A1 (de) *	2008-04-10	2011-01-26	Gilead Sciences, Inc.	Bicyclischen stickstoff enthaltende heterocyclische verbindungen zur verwendung als inhibitoren von stearoyl-coa-desaturase
GB0810902D0 (en)	2008-06-13	2008-07-23	Astex Therapeutics Ltd	New compounds
US20100267752A1 (en) *	2008-10-15	2010-10-21	Gilead Palo Alto, Inc.	3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
AU2009325398A1 (en)	2008-12-12	2010-06-17	Msd K.K.	Dihydropyrimidopyrimidine derivative
WO2010067888A1 (en) *	2008-12-12	2010-06-17	Banyu Pharmaceutical Co.,Ltd.	Dihydropyrimidopyrimidine derivatives
GB0906470D0 (en)	2009-04-15	2009-05-20	Astex Therapeutics Ltd	New compounds
GB0906472D0 (en)	2009-04-15	2009-05-20	Astex Therapeutics Ltd	New compounds
US8663210B2 (en)	2009-05-13	2014-03-04	Novian Health, Inc.	Methods and apparatus for performing interstitial laser therapy and interstitial brachytherapy
WO2012088266A2 (en)	2010-12-22	2012-06-28	Incyte Corporation	Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
US20150087687A1 (en)	2012-03-23	2015-03-26	Dennis Brown	Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo
SMT202000673T1 (it)	2012-06-13	2021-01-05	Incyte Holdings Corp	Composti triciclici sostituiti come inibitori di fgfr
WO2014026125A1 (en)	2012-08-10	2014-02-13	Incyte Corporation	Pyrazine derivatives as fgfr inhibitors
US9266892B2 (en)	2012-12-19	2016-02-23	Incyte Holdings Corporation	Fused pyrazoles as FGFR inhibitors
CA2907243C (en)	2013-03-15	2021-12-28	Celgene Avilomics Research, Inc.	Substituted dihydropyrimidopyrimidinone compounds and pharmaceutical compositions thereof use fgfr4 inhibitor
AR095464A1 (es)	2013-03-15	2015-10-21	Celgene Avilomics Res Inc	Compuestos de heteroarilo y usos de los mismos
BR112015022191A8 (pt) *	2013-03-15	2018-01-23	Celgene Avilomics Res Inc	compostos heteroarila e usos dos mesmos
SG11201508328PA (en)	2013-04-19	2015-11-27	Incyte Corp	Bicyclic heterocycles as fgfr inhibitors
PL3122358T3 (pl)	2014-03-26	2021-06-14	Astex Therapeutics Ltd.	Połączenia inhibitorów fgfr i cmet w leczeniu nowotworu
JP6631616B2 (ja)	2014-07-26	2020-01-15	ノース・アンド・サウス・ブラザー・ファーマシー・インベストメント・カンパニー・リミテッド	ＣＤＫ阻害剤としての２−アミノ−ピリド［２，３−ｄ］ピリミジン−７（８Ｈ）−オン誘導体及びその使用
EP3549583A1 (de)	2014-10-10	2019-10-09	Pfizer Inc	Synergistische auristatinkombinationen
US10851105B2 (en)	2014-10-22	2020-12-01	Incyte Corporation	Bicyclic heterocycles as FGFR4 inhibitors
CN104478742A (zh) *	2014-11-24	2015-04-01	苏州乔纳森新材料科技有限公司	一种氟代化合物及其制备方法
JOP20200201A1 (ar)	2015-02-10	2017-06-16	Astex Therapeutics Ltd	تركيبات صيدلانية تشتمل على n-(3.5- ثنائي ميثوكسي فينيل)-n'-(1-ميثيل إيثيل)-n-[3-(ميثيل-1h-بيرازول-4-يل) كينوكسالين-6-يل]إيثان-1.2-ثنائي الأمين
MA41551A (fr)	2015-02-20	2017-12-26	Incyte Corp	Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
WO2016134294A1 (en)	2015-02-20	2016-08-25	Incyte Corporation	Bicyclic heterocycles as fgfr4 inhibitors
UA121669C2 (uk)	2015-02-20	2020-07-10	Інсайт Корпорейшн	Біциклічні гетероцикли як інгібітори fgfr
WO2018033815A1 (en) *	2016-08-15	2018-02-22	Pfizer Inc.	Pyridopyrimdinone cdk2/4/6 inhibitors
GB201703881D0 (en)	2017-03-10	2017-04-26	Almac Discovery Ltd	Pharmaceutical compounds
AR111960A1 (es)	2017-05-26	2019-09-04	Incyte Corp	Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
CN109836427B (zh) *	2017-11-29	2022-04-15	暨南大学	嘧啶并嘧啶酮类化合物及其应用
FI3788047T3 (fi)	2018-05-04	2024-11-02	Incyte Corp	Fgft-estäjän kiinteitä muotoja ja menetelmiä niiden valmistamiseksi
MX2020011639A (es)	2018-05-04	2021-02-15	Incyte Corp	Sales de un inhibidor de receptores de factor de crecimiento de fibroblastos (fgfr).
KR20220050832A (ko) *	2018-12-27	2022-04-25	르 라보레또레 쎄르비에르	Mat2A의 AZA-헤테로이환 억제제 및 암 치료를 위한 사용 방법
WO2020185532A1 (en)	2019-03-08	2020-09-17	Incyte Corporation	Methods of treating cancer with an fgfr inhibitor
WO2021007269A1 (en)	2019-07-09	2021-01-14	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
WO2021067374A1 (en)	2019-10-01	2021-04-08	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
JOP20220083A1 (ar)	2019-10-14	2023-01-30	Incyte Corp	حلقات غير متجانسة ثنائية الحلقة كمثبطات لـ fgfr
US11566028B2 (en)	2019-10-16	2023-01-31	Incyte Corporation	Bicyclic heterocycles as FGFR inhibitors
GB201915828D0 (en) *	2019-10-31	2019-12-18	Cancer Research Tech Ltd	Compounds, compositions and therapeutic uses thereof
PE20221504A1 (es)	2019-12-04	2022-09-30	Incyte Corp	Derivados de un inhibidor de fgfr
EP4069696A1 (de)	2019-12-04	2022-10-12	Incyte Corporation	Tricyclische heterocyclen als fgfr-inhibitoren
WO2021146424A1 (en)	2020-01-15	2021-07-22	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
EP4323405A1 (de)	2021-04-12	2024-02-21	Incyte Corporation	Kombinationstherapie mit einem fgfr-inhibitor und einem auf nectin-4 abzielenden mittel
JP2024522189A (ja)	2021-06-09	2024-06-11	インサイト・コーポレイション	Ｆｇｆｒ阻害剤としての三環式ヘテロ環
CN116253735A (zh) *	2021-12-10	2023-06-13	江苏开元药业有限公司	嘧啶并嘧啶酮类化合物及其应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2949466A (en)	1958-03-04	1960-08-16	Parke Davis & Co	Pyrimidine compounds and means of producing the same
US3912723A (en)	1971-03-29	1975-10-14	Pfizer	2-Phenyl-as-triazine-3,5(2H,4H)diones
US4425346A (en)	1980-08-01	1984-01-10	Smith And Nephew Associated Companies Limited	Pharmaceutical compositions
JPS60226882A (ja)	1984-04-24	1985-11-12	Nippon Zoki Pharmaceut Co Ltd	新規ピリミドピリミジン誘導体
US5654307A (en)	1994-01-25	1997-08-05	Warner-Lambert Company	Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
IL112249A (en)	1994-01-25	2001-11-25	Warner Lambert Co	Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
EP0786997A4 (de)	1994-10-27	1998-03-11	Merck & Co Inc	Muscarinantagonisten
WO1996015128A2 (en)	1994-11-14	1996-05-23	Warner-Lambert Company	6-ARYL PYRIDO[2,3-d]PYRIMIDINES AND NAPHTHYRIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION
IL117923A (en)	1995-05-03	2000-06-01	Warner Lambert Co	Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds
DE69710712T3 (de)	1996-04-12	2010-12-23	Warner-Lambert Co. Llc	Umkehrbare inhibitoren von tyrosin kinasen
EP1003745B1 (de) *	1997-08-20	2004-12-29	Warner-Lambert Company Llc	Naphthyridinone zur hemmung der durch protein-tyrosin-kinase und zellzyklus kinase hervorgerufenen zellvermehrung
GEP20033093B (en)	1998-05-26	2003-10-27	Warner Lambert Co	Bicyclic Pyrimidines and Bicyclic 3,4-Dihydropyrimidines as Inhibitors of Cellular Proliferation, Compositions Containing Them and Methods for Treating Cell Proliferative Disorders
ES2228123T3 (es)	1998-10-23	2005-04-01	F. Hoffmann-La Roche Ag	Heterociclos de nitrogeno biciclicos.
WO2001019825A1 (en) *	1999-09-15	2001-03-22	Warner-Lambert Company	Pteridinones as kinase inhibitors
TR200201058T2 (tr)	1999-10-21	2002-07-22	F.Hoffmann-La Roche Ag	P38 protein kinaz inhibitörleri olarak, alkilaminoyla ornatılmış bisiklik, azotlu heterosikller
AU776250B2 (en)	1999-10-21	2004-09-02	F. Hoffmann-La Roche Ag	Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase
MY141144A (en)	2000-03-02	2010-03-15	Smithkline Beecham Corp	1, 5-disubstituted-3,4-dihydro-1h-pyrimido 4,5-dipyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
ES2311532T3 (es) *	2000-08-04	2009-02-16	Warner-Lambert Company Llc	2-(4-pirdil)amino-6-dialcoxifenil-pirido(2.3-d)pirimidin-7-onas.
MXPA03000289A (es) *	2000-08-04	2003-06-06	Warner Lambert Co	Proceso para preparar 2-(4-piridil) amino-6-dialquiloxifenil-pirido (2,3-d) pirimidin-7-onas..
CA2424057A1 (en) *	2000-08-04	2003-04-03	Warner-Lambert Company	Process for preparing 2-(4-pyridyl) amino-6-dialkyloxyphenyl-pyrido [2,3-d]pyrimidin-7-ones

2003
- 2003-07-17 PA PA20038577501A patent/PA8577501A1/es unknown
- 2003-07-17 US US10/621,983 patent/US7196090B2/en not_active Expired - Fee Related
- 2003-07-21 EP EP03771234A patent/EP1549651B1/de not_active Expired - Lifetime
- 2003-07-21 BR BR0312867-9A patent/BR0312867A/pt not_active IP Right Cessation
- 2003-07-21 ES ES03771234T patent/ES2335659T3/es not_active Expired - Lifetime
- 2003-07-21 MX MXPA05000814A patent/MXPA05000814A/es unknown
- 2003-07-21 CA CA002493633A patent/CA2493633C/en not_active Expired - Fee Related
- 2003-07-21 JP JP2004524024A patent/JP2005538992A/ja active Pending
- 2003-07-21 DE DE60330694T patent/DE60330694D1/de not_active Expired - Lifetime
- 2003-07-21 AT AT03771234T patent/ATE452891T1/de not_active IP Right Cessation
- 2003-07-21 WO PCT/IB2003/003359 patent/WO2004011465A1/en active Application Filing
- 2003-07-21 AU AU2003249442A patent/AU2003249442A1/en not_active Abandoned
- 2003-07-21 PE PE2003000722A patent/PE20040688A1/es not_active Application Discontinuation
- 2003-07-23 GT GT200300150A patent/GT200300150A/es unknown
- 2003-07-23 AR AR20030102643A patent/AR040513A1/es unknown
- 2003-07-24 HN HN2003000227A patent/HN2003000227A/es unknown
- 2003-07-24 UY UY27906A patent/UY27906A1/es not_active Application Discontinuation
- 2003-07-24 TW TW092120237A patent/TW200413375A/zh unknown

Also Published As

Publication number	Publication date
BR0312867A (pt)	2005-06-14
EP1549651B1 (de)	2009-12-23
CA2493633A1 (en)	2004-02-05
DE60330694D1 (de)	2010-02-04
EP1549651A1 (de)	2005-07-06
US7196090B2 (en)	2007-03-27
HN2003000227A (es)	2005-10-20
AU2003249442A1 (en)	2004-02-16
MXPA05000814A (es)	2005-04-19
GT200300150A (es)	2004-06-08
US20040019210A1 (en)	2004-01-29
AR040513A1 (es)	2005-04-06
PA8577501A1 (es)	2004-02-07
PE20040688A1 (es)	2004-10-06
ES2335659T3 (es)	2010-03-31
TW200413375A (en)	2004-08-01
CA2493633C (en)	2009-04-07
WO2004011465A1 (en)	2004-02-05
JP2005538992A (ja)	2005-12-22
UY27906A1 (es)	2004-02-27

Publication	Publication Date	Title
ATE452891T1 (de)	2010-01-15	Pyrimidopyrimidone als kinaseinhibitoren
ATE505471T1 (de)	2011-04-15	Azaindol-kinaseinhibitoren
ATE404564T1 (de)	2008-08-15	Diazepinoindolderivate als kinaseinhibitoren
DE60313872D1 (de)	2007-06-28	Pyrazoloä1,5-aüpyrimidine als hemmstoffe cyclin-abhängiger kinasen
DE602004025258D1 (de)	2010-03-11	Aminotriazol-verbindungen als proteinkinase-hemmer
IS7599A (is)	2004-12-15	Heterósýklískir kínasatálmar
ATE443706T1 (de)	2009-10-15	Pyrrolotriazinverbindungen als kinaseinhibitoren
DE60329282D1 (de)	2009-10-29	Cyano-pyrrolidine als DPP-IV Inhibitoren
ATE520671T1 (de)	2011-09-15	Pyrimidin-harnstoff-derivate als kinase-hemmer
ATE437876T1 (de)	2009-08-15	Hexahydropyridoisochinoline als dpp-iv- inhibitoren
ATE478868T1 (de)	2010-09-15	Pyrrolodihydroisochinoline als pde10- inhibitoren
DE60320933D1 (de)	2008-06-26	Rho-kinase inhibitoren
DE602004018837D1 (de)	2009-02-12	Ptidase-iv-inhibitoren
ATE368651T1 (de)	2007-08-15	Pyridazinon-derivate als gsk-3beta-hemmer
DE50304983D1 (de)	2006-10-19	Heteroaryloxy-substituierte phenylaminopyrimidine als rho-kinaseinhibitoren
ATE525377T1 (de)	2011-10-15	Imidazoä1,5-aüpyrazine als inhibitoren von tyrosinkinase
DE602004012154D1 (de)	2008-04-10	Pyridoä2,3-düpyrimidin-2,4-diamine als pde-2-inhibitoren
DE60325032D1 (de)	2009-01-15	2-hydroxy-3-heteroarylindole derivate als gsk3 inhibitoren
DE60315862D1 (de)	2007-10-04	Dihydropyridinonderivate als hne-inhibitoren
ATE400271T1 (de)	2008-07-15	Aryl-pyridinderivate als 11-beta-hsd1-hemmer
ATE420076T1 (de)	2009-01-15	Indozolonderivate als 11b-hsd1-inhibitoren
DE60324208D1 (de)	2008-11-27	Biarylsulfonamide als mmp-inhibitoren
DE502004006055D1 (de)	2008-03-13	6-arylamino-5-cyano-4-pyrimidinone als pde9a-inhibitoren
DE602004026905D1 (de)	2010-06-10	2-aminoaryloxazol-verbindungen als tyrosinkinase-hemmer
DE60322544D1 (de)	2008-09-11	Glycinamid-derivate als raf-kinase-hemmer

Legal Events

Date	Code	Title	Description
2010-06-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties